Search results
Results From The WOW.Com Content Network
Vasant "Vas" Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018. He briefly worked at McKinsey before joining Novartis in 2005, where he has held a range of leadership roles, including Global Head of Development for Novartis Vaccines and Global Head of Drug Development & Chief Medical ...
Novartis AG. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...
Theranos Inc. ( / ˈθɛr.ən.oʊs /) was an American privately held corporation [5] that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$ 700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 ...
Lacks died of cervical cancer later in 1951 at age 31. The new lawsuit said Switzerland-based Novartis used the HeLa cells in developing its herpes drug Famvir, cancer treatment Kymriah and spinal ...
By Sriparna Roy. (Reuters) -The U.S. Food and Drug Administration has approved the use of Novartis' drug to reduce excess protein in the urine of patients with a type of kidney disease, the health ...
Inclisiran, sold under the brand name Leqvio, is a medication used for the treatment of high low-density lipoprotein (LDL) cholesterol and for the treatment of people with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk-equivalents, and heterozygous familial hypercholesterolemia (HeFH). [5] [7] [6] [9] It is a small interfering RNA ...
Jimenez joined Novartis in 2007 as Division Head of Novartis Pharmaceutical and was named CEO in 2010 by his predecessor and Chairman Daniel Vasella.. During his time at Novartis, Jimenez increasingly applied standard business metrics to pharma cash flow, purchasing and competitive bidding, confident that his experience in consumer goods would help to realize improvements in Novartis' operations.
François Adrianus van Houten. ( 1960-04-26) 26 April 1960 (age 64) Netherlands. Occupation. CEO. François Adrianus "Frans" van Houten (born 26 April 1960) is a Dutch businessman. He served as the CEO of Royal Philips Electronics (known universally as Philips) from 1 April 2011 to 15 October 2022.